Journal

HGG advances
ISSN: 2666-2477
Titre abrégé: HGG Adv
Pays: United States
ID NLM: 101772885

Informations de publication

Date de publication:
12 01 2023
Historique:
received: 30 08 2022
accepted: 31 10 2022
entrez: 25 11 2022
pubmed: 26 11 2022
medline: 26 11 2022
Statut: epublish

Résumé

Pleiotropic genetic factors (e.g., DNA polymorphisms) may be involved in the initiation of neuroblastoma (NB) and coronary artery disease (CAD) given their common origin from defects in neural crest development. To discover novel NB susceptibility genes, we conducted a three-stage survey including a meta-analysis of NB and CAD genome-wide association data, prioritization of NB causal variants, and validation in an independent cohort of affected individuals-control subjects. The lead SNP, rs13337397 at the 16q23.1 locus, associated with both diseases in the meta-analysis and with NB in the validation study. All the SNPs in linkage disequilibrium with rs13337397 were annotated using the H3K27ac epigenetic marker of neural crest cells (NCC) and NB cell lines. Indeed, we identified the functional SNP rs13337017, mapping within an enhancer of NCCs and NB cell lines and showing long-range interactions with

Identifiants

pubmed: 36425957
doi: 10.1016/j.xhgg.2022.100158
pii: S2666-2477(22)00075-6
pmc: PMC9678964
doi:

Substances chimiques

Transcription Factors 0

Types de publication

Meta-Analysis Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

100158

Informations de copyright

© 2022 The Authors.

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

Cancer Res. 2022 Apr 1;82(7):1193-1207
pubmed: 35101866
Circ Res. 2011 Apr 15;108(8):940-9
pubmed: 21350214
Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1565-73
pubmed: 22806168
PLoS Genet. 2009 Jun;5(6):e1000529
pubmed: 19543373
Chromosoma. 2015 Jun;124(2):153-62
pubmed: 25547403
Nature. 2010 Feb 4;463(7281):621-6
pubmed: 20054295
J Natl Cancer Inst. 2015 Aug 29;107(11):
pubmed: 26319099
Nat Rev Dis Primers. 2016 Nov 10;2:16078
pubmed: 27830764
Int J Cancer. 2005 Feb 20;113(5):699-705
pubmed: 15499635
Mol Oncol. 2016 Feb;10(2):344-59
pubmed: 26598443
Mech Dev. 2009 Jan-Feb;126(1-2):80-9
pubmed: 18955134
Development. 2012 Oct;139(20):3806-16
pubmed: 22991445
Cancer Treat Res. 2010;155:65-84
pubmed: 20517688
J Neurochem. 2002 Mar;80(5):905-16
pubmed: 11948255
Oncogene. 1998 Dec 17;17(24):3137-43
pubmed: 9872329
Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):17921-6
pubmed: 24127591
Cell Prolif. 2002 Aug;35(4):207-19
pubmed: 12153613
Database (Oxford). 2017 Jan 1;2017:
pubmed: 28605766
J Clin Oncol. 2017 Aug 1;35(22):2580-2587
pubmed: 28471719
Cancer Discov. 2016 Sep;6(9):1052-67
pubmed: 27432226
J Intern Med. 2021 Nov;290(5):980-992
pubmed: 34237186
Nat Genet. 2014 Sep;46(9):994-1000
pubmed: 25086665
Nat Genet. 2017 Sep;49(9):1408-1413
pubmed: 28740262
Nat Genet. 2012 Oct;44(10):1126-30
pubmed: 22941191
Hum Mol Genet. 2016 Jul 1;25(13):2873-2880
pubmed: 27094129
J Natl Cancer Inst. 2004 Mar 17;96(6):434-42
pubmed: 15026468
Gene. 1999 Jul 22;235(1-2):19-30
pubmed: 10415329
Cancer Metastasis Rev. 2020 Mar;39(1):275-285
pubmed: 31927719
Nat Genet. 2013 Mar;45(3):279-84
pubmed: 23334666
J Cell Mol Med. 2020 Apr;24(7):4072-4081
pubmed: 32103589
Cancer Commun (Lond). 2020 Nov;40(11):641-646
pubmed: 32780923
Cancer Res. 2016 Sep 1;76(17):5103-14
pubmed: 27197191
Birth Defects Res C Embryo Today. 2015 Jun;105(2):87-95
pubmed: 26043871
Am J Med Genet A. 2010 Dec;152A(12):2984-94
pubmed: 20734335
Philos Trans R Soc Lond B Biol Sci. 2013 May 06;368(1620):20120360
pubmed: 23650634
Nat Genet. 2011 Mar 06;43(4):339-44
pubmed: 21378988
J Biol Chem. 2013 Sep 27;288(39):27927-39
pubmed: 23902762
Nat Commun. 2012;3:1267
pubmed: 23232397
Circ Cardiovasc Genet. 2011 Jun;4(3):327-9
pubmed: 21673312
Nat Genet. 2017 Sep;49(9):1392-1397
pubmed: 28714974
Nat Genet. 2015 Aug;47(8):911-6
pubmed: 26098869
Hum Mol Genet. 2022 Mar 21;31(6):863-874
pubmed: 34605909
J Biol Chem. 2009 Oct 16;284(42):29109-24
pubmed: 19674970
Birth Defects Res C Embryo Today. 2014 Sep;102(3):324-32
pubmed: 25227212
J Dermatol Sci. 2012 Apr;66(1):20-8
pubmed: 22391242
PLoS Genet. 2017 May 18;13(5):e1006787
pubmed: 28545128
Nat Rev Cancer. 2003 Mar;3(3):203-16
pubmed: 12612655
Sci Rep. 2017 Apr 03;7:45022
pubmed: 28367969
Nat Commun. 2016 Jul 01;7:12050
pubmed: 27363682
Mol Ther Nucleic Acids. 2020 Aug 14;22:17-26
pubmed: 32891980
Cleft Palate Craniofac J. 2011 Jan;48(1):109-16
pubmed: 20500075
Development. 2008 Feb;135(3):473-81
pubmed: 18094025
Nature. 2015 Oct 29;526(7575):700-4
pubmed: 26466568
Cell Prolif. 2015 Dec;48(6):631-42
pubmed: 26486273
Curr Opin Genet Dev. 2017 Feb;42:81-90
pubmed: 28458126
Cancer Res. 2020 Feb 1;80(3):382-393
pubmed: 31784426
Genes (Basel). 2019 Aug 30;10(9):
pubmed: 31480262
Science. 2007 Dec 21;318(5858):1917-20
pubmed: 18029452
NPJ Genom Med. 2020 Apr 15;5:18
pubmed: 32337068

Auteurs

Daniela Formicola (D)

Dipartimento di Neurobiologia e Medicina Molecolare, IRCSS Fondazione Stella Maris, 56128 Pisa, Italy.
CEINGE Biotecnologie Avanzate Franco Salvatore, Via Gaetano Salvatore 486, 80145 Napoli, Italy.
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Via Pansini, 5, 80131 Napoli, Italy.

Vito Alessandro Lasorsa (VA)

CEINGE Biotecnologie Avanzate Franco Salvatore, Via Gaetano Salvatore 486, 80145 Napoli, Italy.
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Via Pansini, 5, 80131 Napoli, Italy.

Sueva Cantalupo (S)

CEINGE Biotecnologie Avanzate Franco Salvatore, Via Gaetano Salvatore 486, 80145 Napoli, Italy.
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Via Pansini, 5, 80131 Napoli, Italy.

Alessandro Testori (A)

CEINGE Biotecnologie Avanzate Franco Salvatore, Via Gaetano Salvatore 486, 80145 Napoli, Italy.
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Via Pansini, 5, 80131 Napoli, Italy.
Division of Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Antonella Cardinale (A)

CEINGE Biotecnologie Avanzate Franco Salvatore, Via Gaetano Salvatore 486, 80145 Napoli, Italy.
Department of Pediatric Hematology and Oncology, Bambino Gesù Children's Hospital, IRCCS, Roma, Italy.

Marianna Avitabile (M)

CEINGE Biotecnologie Avanzate Franco Salvatore, Via Gaetano Salvatore 486, 80145 Napoli, Italy.
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Via Pansini, 5, 80131 Napoli, Italy.

Sharon Diskin (S)

Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Achille Iolascon (A)

CEINGE Biotecnologie Avanzate Franco Salvatore, Via Gaetano Salvatore 486, 80145 Napoli, Italy.
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Via Pansini, 5, 80131 Napoli, Italy.

Mario Capasso (M)

CEINGE Biotecnologie Avanzate Franco Salvatore, Via Gaetano Salvatore 486, 80145 Napoli, Italy.
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Via Pansini, 5, 80131 Napoli, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH